GS-010 Outcomes of 48 weeks of therapy and subsequent 24-week post-treatment period with tobevibart (VIR-3434) and elebsiran (VIR-2218) with or without pegylated interferon alfa-2a in chronic hepatitis B virus infection. Findings from the MARCH study
医学
句号（音乐）
内科学
哲学
美学
作者
Edward Gane,Kosh Agarwal,Jeong Heo,Alina Jucov,Young‐Suk Lim,Adrian Streinu‐Cercel,Grace Lai‐Hung Wong,Ki Tae Yoon,Andre Arizpe,Sergio Parra,Keith Boundy,Shuli Yu,Li Wang,Karen E. Tracy,Andrea L. Cathcart,Todd Correll,Carey Hwang,Man–Fung Yuen
PDF的下载单位、IP信息已删除
(2025-6-4)
null
GingerF
tuanheqi
qing
无情的踏歌
Criminology34
Mic
维奈克拉
轨迹
YifanWang
Xhhaai
Fancy
无极微光
kento
HJJHJH
寻道图强
andrele
Cooper
不言而喻
Hayat
NattyPoe
寒冷的咖啡
MchemG
BowieHuang
皖公网安备34019202002308
